Nick van Es Selected Research

Nick van Es Research Topics

Disease

39	Neoplasms (Cancer) 02/2024 - 05/2014
36	Venous Thromboembolism 03/2024 - 09/2014
22	Hemorrhage 03/2024 - 06/2014
13	Pulmonary Embolism 01/2023 - 08/2016
7	COVID-19 05/2024 - 10/2020
7	Venous Thrombosis (Deep-Vein Thrombosis) 03/2023 - 10/2015
3	Thrombosis (Thrombus) 03/2024 - 01/2015
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2022 - 08/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2023 - 01/2018
2	Thrombophilia 01/2022 - 01/2019
2	Thromboembolism 10/2021 - 06/2013
2	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2019 - 01/2015
2	Thrombocytopenia (Thrombopenia) 01/2015 - 06/2013
1	Glioblastoma (Glioblastoma Multiforme) 12/2023
1	Sepsis (Septicemia) 03/2023
1	Disseminated Intravascular Coagulation 03/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022
1	Cytokine Release Syndrome 01/2022
1	Sickle Cell Trait 01/2022
1	Atrial Fibrillation 01/2022
1	Neoplasm Metastasis (Metastasis) 06/2021
1	Lung Neoplasms (Lung Cancer) 10/2020
1	Infections 10/2020
1	Circulating Neoplastic Cells 08/2020
1	Fibrosis (Cirrhosis) 10/2018
1	Ischemic Stroke 10/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2018
1	Body Weight (Weight, Body) 02/2018
1	Upper Extremity Deep Vein Thrombosis 12/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 08/2016
1	Vascular System Injuries 06/2014
1	Acute Coronary Syndrome 06/2013

Drug/Important Bio-Agent (IBA)

31	AnticoagulantsIBA 03/2024 - 06/2013
13	fibrin fragment D (D-dimer)IBA 01/2023 - 08/2016
9	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2022 - 06/2013
8	edoxabanIBA 01/2023 - 11/2015
7	Vitamin K FDA Link 01/2023 - 09/2014
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 03/2016
5	Thromboplastin (Tissue Factor)IBA 03/2023 - 06/2014
5	Dalteparin (Dalteparin Sodium)FDA Link 12/2021 - 02/2018
4	Heparin (Liquaemin)FDA LinkGeneric 10/2020 - 06/2013
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2024 - 01/2017
3	Factor Xa InhibitorsIBA 01/2019 - 11/2015
2	RNA (Ribonucleic Acid)IBA 12/2023 - 01/2023
2	Contraceptive Agents (Contraceptives)IBA 01/2023 - 01/2022
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2023 - 08/2016
2	Estrogens (Estrogen)FDA Link 01/2023 - 01/2022
2	apixabanIBA 01/2022 - 01/2019
2	ORALIT (ORS)IBA 12/2021 - 01/2018
1	Fibrinogen (Factor I)FDA Link 02/2024
1	factor V LeidenIBA 11/2023
1	Prothrombin (Factor II)IBA 11/2023
1	Peptide Hydrolases (Proteases)FDA Link 10/2023
1	LipopolysaccharidesIBA 03/2023
1	Tamoxifen FDA LinkGeneric 01/2023
1	C-Reactive ProteinIBA 01/2022
1	Growth Differentiation Factor 15IBA 01/2022
1	Lipoprotein(a)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 12/2021
1	PlatinumIBA 09/2020
1	Gemcitabine FDA Link 09/2020
1	Messenger RNA (mRNA)IBA 08/2020
1	Circulating Tumor DNAIBA 08/2020
1	cupric sulfide (CuS)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019
1	AntithrombinsIBA 01/2019
1	micaIBA 07/2018
1	FibrinIBA 01/2018
1	Factor Xa (Coagulation Factor Xa)IBA 01/2018
1	pro-brain natriuretic peptide (1-76)IBA 01/2018
1	Quinidine (Chinidin)FDA LinkGeneric 08/2016
1	Verapamil (Calan)FDA LinkGeneric 08/2016
1	Warfarin (Coumadin)FDA LinkGeneric 08/2016
1	CreatinineIBA 08/2016
1	Blood Coagulation Factors (Coagulation Factor)IBA 08/2016
1	PlacebosIBA 08/2016
1	Angiogenic ProteinsIBA 06/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2014
1	Hemostatics (Antihemorrhagics)IBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	Thrombin FDA Link 06/2014
1	Fondaparinux (Arixtra)FDA Link 06/2013

Therapy/Procedure

14	Therapeutics 05/2024 - 05/2014
9	Drug Therapy (Chemotherapy) 12/2021 - 03/2016
3	Duration of Therapy 01/2021 - 02/2018
3	Central Venous Catheters 07/2020 - 03/2016
1	Home Nursing (Nursing, Home) 05/2024
1	Length of Stay 04/2024
1	Secondary Prevention 04/2017
1	Percutaneous Coronary Intervention 06/2013